Restatement and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2022

Reclassification [Line Items]

Summary of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss per Share

The following table sets forth the potentially dilutive securities that have been excluded from the calculation of diluted net loss per share because to include them would be anti-dilutive (in common stock equivalent shares):

	Three Months Ended March 31,
	2022		2021
Stock options		2,962,177		1,762,605
Restricted stock units		42,879		—
Total		3,005,056		1,762,605

Prior Period Error Correction Adjustment

Reclassification [Line Items]

Summary of Previously Issued Unaudited Statements Affected by the Restatement

Set forth below are the adjustments to the Company’s previously issued unaudited statements of operations and comprehensive loss and unaudited balance sheet for the period affected by the restatement. The restatement adjustments did not affect the net cash used in operating activities in the Company’s statements of cash flows.

(in thousands, except per share data)	Three Months Ended March 31, 2022
Statement of Operations and Comprehensive Loss	As Reported			Adjustment			As Restated
Collaboration revenue	$	5,367		$	(4,899	)	$	468
Loss from operations	$	(7,026	)	$	(4,899	)	$	(11,925	)
Net loss	$	(7,012	)	$	(4,899	)	$	(11,911	)
Net loss per share attributable to common stockholders—basic and    diluted	$	(0.54	)	$	(0.38	)	$	(0.92	)
	As of March 31, 2022
Balance Sheet	As Reported			Adjustment			As Restated
Deferred revenue	$	10,060		$	4,163		$	14,223
Deferred revenue, net of current portion	$	1,288		$	736		$	2,024
Total liabilities	$	19,189		$	4,899		$	24,088
Accumulated deficit	$	(200,409	)	$	(4,899	)	$	(205,308	)
Stockholders' equity	$	28,156		$	(4,899	)	$	23,257
	Three Months Ended March 31, 2022
Statement of Cash Flows	As Reported			Adjustment			As Restated
Net loss	$	(7,012	)	$	(4,899	)	$	(11,911	)
Deferred revenue	$	(367	)	$	4,899		$	4,532